The United Laboratories International Holdings Announces Proposed HK\$200 Million Share Buy-Back
Hong Kong, 11 June 2026 – The United Laboratories International Holdings Limited (Stock Code: 3933) has announced a significant new initiative, revealing its intention to repurchase up to HK\$200 million worth of its ordinary shares in the open market. This move will be made under the general mandate previously granted by shareholders at the annual general meeting held on 25 June 2025.
Key Points of the Announcement
- Share Buy-Back Plan: The Board intends to buy back shares with a total value of up to HK\$200 million. These shares will be purchased in the open market at times deemed appropriate by the Board.
- Financing: The buy-back will be entirely funded by the Company’s internal cash resources, reflecting the Board’s confidence in the Company’s solid and healthy financial position.
- Cancellation of Shares: All shares repurchased under this plan will be cancelled, reducing the total number of shares outstanding and potentially increasing the value of remaining shares.
- Purpose and Rationale: The Board believes that this share buy-back and subsequent cancellation is in the best interest of both the Company and its shareholders. The action is expected to enhance shareholder value and improve returns.
Important Information for Shareholders
- Market Impact: The announcement of a substantial share buy-back program is a price-sensitive development. Such actions typically signal management’s confidence in the company’s prospects and may positively influence the share price by reducing the supply of shares and enhancing earnings per share.
- Discretionary Execution: The execution of the buy-back is at the Board’s absolute discretion and will depend on prevailing market conditions. There is no guarantee regarding the timing, quantity, or price of any actual share repurchases.
- Investor Caution: Shareholders and potential investors are advised to exercise caution when trading in the Company’s securities, as there is no assurance that the buy-back will be carried out as planned or at all.
Board and Management
The Board of United Laboratories International Holdings Limited is led by Chairman Mr. Tsoi Hoi Shan, with executive directors Mr. Leung Wing Hon, Ms. Choy Siu Chit, Mr. Fang Yu Ping, and Ms. Zou Xian Hong. Independent non-executive directors include Mr. Chong Peng Oon, Prof. Song Ming, and Dr. Fu Qiushi.
Conclusion
This proposed share buy-back represents a significant corporate action that demonstrates the Board’s confidence in the Company’s fundamentals and financial health. If executed, it has the potential to positively impact the Company’s share value and deliver enhanced returns for shareholders.
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors are advised to exercise caution and consult with their financial advisors before making any investment decisions. The actual execution of the share buy-back is subject to market conditions and at the sole discretion of the Board.
